Related Experiment Video
Updated: Sep 26, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
[Irritable bowel syndrome : physiopathology and complementary management].
Fanny Salamin1, Niels Gobin1, Jean-Michel Cereda2
1Service de médecine interne générale, Centre hospitalier du Valais romand, Hôpital du Valais, Hôpital de Sion, 1951 Sion.
Irritable Bowel Syndrome (IBS) management remains challenging despite recent advances in understanding its mechanisms. This review explores IBS pathophysiology to suggest complementary therapies beyond conventional treatments for better long-term symptom control.
Area of Science:
- Gastroenterology
- Internal Medicine
- Physiopathology
Background:
- Recent research has elucidated several physiopathological mechanisms underlying Irritable Bowel Syndrome (IBS).
- Current therapeutic options for IBS often provide incomplete and unsatisfying long-term symptom control.
- A significant gap exists between understanding IBS mechanisms and effective, sustainable patient management.
Purpose of the Study:
- To review the current understanding of physiopathological mechanisms implicated in Irritable Bowel Syndrome.
- To identify potential complementary management strategies for IBS.
- To offer alternatives to conventional IBS treatments based on mechanistic insights.
Main Methods:
- Systematic literature review of studies published in the last ten years.
- Analysis of physiopathological mechanisms of Irritable Bowel Syndrome.
- Synthesis of findings to propose complementary therapeutic approaches.
Main Results:
- Multiple complex mechanisms contribute to IBS development and symptom presentation.
- Existing treatments offer limited efficacy for sustained symptom management in a significant patient subset.
- Understanding these mechanisms opens avenues for novel or adjunctive therapeutic strategies.
Conclusions:
- A deeper understanding of IBS pathophysiology is crucial for advancing treatment efficacy.
- Complementary management strategies, informed by mechanistic insights, may improve long-term IBS symptom control.
- Further research is warranted to validate and integrate these complementary approaches into standard IBS care.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS